Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1951 Oct;30(10):1125–1142. doi: 10.1172/JCI102533

MULTIPLE MYELOMA. IV. ABNORMAL SERUM COMPONENTS AND BENCE JONES PROTEIN 1

R Wayne Rundles 1,2, Gerald R Cooper 1,2, Robert W Willett 1,2,2
PMCID: PMC436355  PMID: 14888691

Full text

PDF
1125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG J. B. A study of renal function in patients with multiple myeloma. Am J Med Sci. 1950 May;219(5):488–493. doi: 10.1097/00000441-195005000-00003. [DOI] [PubMed] [Google Scholar]
  2. BARR D. P., READER G. G., WHEELER C. H. Cryoglobulinemia; report of two cases with discussion of clinical manifestations, incidence and significance. Ann Intern Med. 1950 Jan;32(1):6-29, illust. doi: 10.7326/0003-4819-32-1-6. [DOI] [PubMed] [Google Scholar]
  3. Gutman A. B., Moore D. H., Gutman E. B., McClellan V., Kabat E. A. FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA. J Clin Invest. 1941 Nov;20(6):765–783. doi: 10.1172/JCI101269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hektoen L., Welker W. H. Immunological differences of crystalline Bence-Jones proteins. Biochem J. 1940 Apr;34(4):487–489. doi: 10.1042/bj0340487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kekwick R. A. The serum proteins in multiple myelomatosis. Biochem J. 1940 Sep;34(8-9):1248–1257. doi: 10.1042/bj0341248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McFarlane A. S. The behaviour of pathological sera in the ultracentrifuge. Biochem J. 1935 May;29(5):1175–1201. doi: 10.1042/bj0291175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Moore D. H., Kabat E. A., Gutman A. B. BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA. J Clin Invest. 1943 Jan;22(1):67–75. doi: 10.1172/JCI101370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. RUNDLES R. W., DILLON M. L., DILLON E. S. Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria. J Clin Invest. 1950 Sep;29(9):1243–1260. doi: 10.1172/JCI102362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. RUNDLES R. W., REEVES R. J. Multiple myeloma. II. Variability of roentgen appearance and effect of urethane therapy on skeletal disease. Am J Roentgenol Radium Ther. 1950 Nov;64(5):799–809. [PubMed] [Google Scholar]
  10. Shapiro S., Ross V., Moore D. H. A VISCOUS PROTEIN OBTAINED IN LARGE AMOUNT FROM THE SERUM OF A PATIENT WITH MULTIPLE MYELOMA. J Clin Invest. 1943 Mar;22(2):137–142. doi: 10.1172/JCI101375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. WUHRMANN F. H., WUNDERLY C., HASSIG A. Immunological investigations in ten cases of plasmacytoma. Br J Exp Pathol. 1950 Aug;31(4):507–514. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES